ResMed RMD Interest Expense
Discontinued — last reported Q3 '26
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by ResMed in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about ResMed's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ResMed's interest expense?
- ResMed (RMD) reported interest expense of $12.29M in Q1 2026.
- How has ResMed's interest expense changed year-over-year?
- ResMed's interest expense increased by 1449.4% year-over-year, from $793K to $12.29M.
- What is the long-term trend for ResMed's interest expense?
- Over 4 years (2021 to 2025), ResMed's interest expense has grown at a -35.6% compound annual growth rate (CAGR), from $23.99M to $4.11M.
- What does interest expense mean?
- The cost of borrowing money to fund business operations.
- How do you interpret interest expense?
- An increase may signal higher debt levels or rising interest rates, potentially impacting future cash flow, while a decrease suggests debt repayment or refinancing at better terms.
- How does interest expense compare across companies?
- Varies significantly based on capital structure; low-debt companies in the medical device sector typically show minimal interest expense.